Back to EUR-Lex homepage

EUR-Lex Access to European Union law

Back to EUR-Lex homepage

This document is an excerpt from the EUR-Lex website

Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a search term to find variations of it (transp*, 32019R*). Use a question mark (?) instead of a single character in your search term to find variations of it (ca?e finds case, cane, care).
Search tips
Need more search options? Use the Advanced search
You are here

Document 52012XC1026(03)

Sommarju ta' deċiżjonijiet tal-Unjoni Ewropea dwar l-awtorizzazzjonijiet għat-tqegħid fis-suq tal-prodotti mediċinali mill- 1 ta' Settembru 2012 sat- 30 ta' Settembru 2012 (Ippubblikat skont l-Artikolu 13 jew l-Artikolu 38 tar-Regolament (KE) Nru 726/2004 tal-Parlament Ewropew u tal-Kunsill)

ĠU C 328, 26.10.2012, p. 1–7 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

26.10.2012   

MT

Il-Ġurnal Uffiċjali tal-Unjoni Ewropea

C 328/1

Sommarju ta' deċiżjonijiet tal-Unjoni Ewropea dwar l-awtorizzazzjonijiet għat-tqegħid fis-suq tal-prodotti mediċinali mill-1 ta' Settembru 2012 sat-30 ta' Settembru 2012

(Ippubblikat skont l-Artikolu 13 jew l-Artikolu 38 tar-Regolament (KE) Nru 726/2004 tal-Parlament Ewropew u tal-Kunsill  (1) )

2012/C 328/01

—   Ħruġ ta' awtorizzazzjoni għat-tqegħid fis-suq (Artikolu 13 tar-Regolament (KE) Nru 726/2004 tal-Parlament Ewropew u tal-Kunsill): Aċċettat

Data tad-deċiżjoni

Isem tal-prodott mediċinali

INN (Denominazzjoni Internazzjonali Komuni)

Detentur tal-awtorizzazzjoni għat-tqegħid fis-suq

Numru tal-entrata fir-Reġistru Komunitarju

Forma farmaċewtika

Kodiċi ATC (Kodiċi Anatomiku Terapewtiku Kimiku)

Data ta' notifika

3.9.2012

Inlyta

Axitinib

Pfizer Limited

Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom

EU/1/12/777/001-006

Pillola miksija b’rita

L01XE17

5.9.2012

3.9.2012

NovoThirteen

catridecacog

Novo Nordisk A/S

Novo Allé, DK-2880 Bagsvaerd, Danmark

EU/1/12/775/001

Trab u solvent għal soluzzjoni għall-injezzjoni

B02BD11

5.9.2012

20.9.2012

Dacogen

decitabine

Janssen-Cilag International NV

Turnhoutseweg 30, B-2340 Beerse, België

EU/1/12/792/001

Trab għal konċentrat għal soluzzjoni għall-infużjoni

L01BC08

24.9.2012

28.9.2012

Enurev Breezhaler

glycopyrronium bromide

Novartis Europharm Limited

Wimblehurst Road, Horsham, West Sussex, RH12 5AB, United Kingdom

EU/1/12/789/001-006

Trab li jittieħed man-nifs, kapsula iebsa

R03BB06

3.10.2012

28.9.2012

Seebri Breezhaler

glycopyrronium bromide

Novartis Europharm Limited

Wimblehurst Road, Horsham, West Sussex, RH12 5AB, United Kingdom

EU/1/12/788/001-006

Trab li jittieħed man-nifs, kapsula iebsa

R03BB06

3.10.2012

28.9.2012

Tovanor Breezhaler

glycopyrronium bromide

Novartis Europharm Limited

Wimblehurst Road, Horsham, West Sussex, RH12 5AB, United Kingdom

EU/1/12/790/001-006

Trab li jittieħed man-nifs, kapsula iebsa

R03BB06

3.10.2012


—   Modifika ta' awtorizzazzjoni għat-tqegħid fis-suq (Artikolu 13 tar-Regolament (KE) Nru 726/2004 tal-Parlament Ewropew u tal-Kunsill): Aċċettat

Data tad-deċiżjoni

Isem tal-prodott mediċinali

Detentur tal-awtorizzazzjoni għat-tqegħid fis-suq

Numru tal-entrata fir-Reġistru Komunitarju

Data ta' notifika

10.9.2012

Advate

Baxter AG

Industriesstrasse 67, 1221 Wien, Österreich

EU/1/03/271/007-010

12.9.2012

10.9.2012

Cialis

Eli Lilly Nederland B.V.

Grootslag 1-5, 3991 RA Houten, Nederland

EU/1/02/237/001-009

12.9.2012

10.9.2012

Entacapone Teva

Teva Pharma B.V.

Computerweg 10, 3542 DR Utrecht, Nederland

EU/1/10/665/001-004

12.9.2012

10.9.2012

JEVTANA

Sanofi-aventis groupe

54, rue de la Boétie, F-75008 France

EU/1/11/676/001

12.9.2012

10.9.2012

Levetiracetam ratiopharm

ratiopharm GmbH

Graf-Arco-Straße 3, D-89079 Ulm, Deutschland

EU/1/11/702/001-031

12.9.2012

10.9.2012

Norvir

Abbott Laboratories Ltd

Abbott House, Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire SL6 4XE, United Kingdom

EU/1/96/016/001

EU/1/96/016/003-008

12.9.2012

10.9.2012

Orgalutran

N.V. Organon

P.O. Box 20, Kloosterstraat 6, 5340 BH Oss, Nederland

EU/1/00/130/001-002

12.9.2012

10.9.2012

Ozurdex

Allergan Pharmaceuticals (Ireland) Ltd

Castlebar Road, Westport, Co. Mayo, Ireland

EU/1/10/638/001

12.9.2012

10.9.2012

Rasilamlo

Novartis Europharm Ltd

Wimblehurst Road, Horsham, West Sussex, RH12 5AB, United Kingdom

EU/1/11/686/001-056

12.9.2012

10.9.2012

Rasitrio

Novartis Europharm Limited

Wimblehurst Road, Horsham, West Sussex, RH12 5AB, United Kingdom

EU/1/11/730/001-060

12.9.2012

10.9.2012

Revlimid

Celgene Europe Limited

1 Longwalk Road, Stockley Park, Uxbridge, Middlesex, UB11 1DB, United Kingdom

EU/1/07/391/001-006

12.9.2012

10.9.2012

Sildenafil Teva

Teva Pharma B.V.

Computerweg 10, 3542 DR Utrecht, Nederland

EU/1/09/584/002-006

EU/1/09/584/008-012

EU/1/09/584/014-018

12.9.2012

10.9.2012

Simponi

Janssen Biologics B.V.

Einsteinweg 101, CB Leiden 2333, Nederland

EU/1/09/546/001-004

12.9.2012

10.9.2012

Somavert

Pfizer Ltd

Ramsgate Road, Sandwich, Kent CT 13 9NJ, United Kingdom

EU/1/02/240/001-004

12.9.2012

10.9.2012

Tamiflu

Roche Registration Limited

6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, United Kingdom

EU/1/02/222/001-005

12.9.2012

10.9.2012

Trobalt

Glaxo Group Limited

Berkeley Avenue, Greenford, Middlesex UB6 0NN, United Kingdom

EU/1/11/681/001-013

12.9.2012

10.9.2012

Xelevia

Merck Sharp & Dohme Ltd

Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/07/382/001-018

12.9.2012

11.9.2012

Clopidogrel ratiopharm

Acino Pharma GmbH

Am Windfeld 35, 83714 Miesbach, Deutschland

EU/1/09/554/001-008

13.9.2012

11.9.2012

Docetaxel Teva

Teva Pharma B.V.

Computerweg 10, 3542 DR Utrecht, Nederland

EU/1/09/611/001-002

13.9.2012

12.9.2012

Clopidogrel Krka

KRKA, d. d., Novo mesto

Šmarješka cesta 6, 8501 Novo mesto, Slovenija

EU/1/09/556/001-011

14.9.2012

12.9.2012

Clopidogrel Krka d.d.

KRKA, d.d., Novo mesto

Šmarješka cesta 6, 8501 Novo mesto, Slovenija

EU/1/09/562/001-009

14.9.2012

12.9.2012

Clopidogrel TAD

TAD Pharma GmbH

Heinz-Lohmann-Straße 5, 27472 Cuxhaven, Deutschland

EU/1/09/555/001-009

14.9.2012

17.9.2012

Atripla

Bristol-Myers Squibb and Gilead Sciences Limited

IDA Business & Technology Park, Carrigtohill, Co. Cork, Ireland

EU/1/07/430/001-002

19.9.2012

17.9.2012

Cervarix

GlaxoSmithKline Biologicals S.A.

rue de l'Institut 89, 1330 Rixensart, Belgique

EU/1/07/419/001-012

19.9.2012

17.9.2012

Clopidogrel ratiopharm GmbH

Acino Pharma GmbH

Am Windfeld 35, 83714 Miesbach, Deutschland

EU/1/09/541/001-008

19.9.2012

17.9.2012

Glubrava

Takeda Global Research and Development Centre (Europe) Ltd

61 Aldwych, London WC2B 4AE, United Kingdom

EU/1/07/421/001-009

19.9.2012

17.9.2012

Levetiracetam Accord

Accord Healthcare Limited

5th Floor Charles House, 108/110 Finchley road, London NW3 5JJ, United Kingdom

EU/1/11/712/001-040

19.9.2012

17.9.2012

Replagal

Shire Human Genetic Therapies AB

Svärdvägen 11D, 182 33 Danderyd, Sverige

EU/1/01/189/001-006

19.9.2012

20.9.2012

Azarga

Alcon Laboratories (UK) Ltd.

Pentagon Park, Boundary Way, Hemel Hempstead, Herts HP2 7UD, United Kingdom

EU/1/08/482/001-002

24.9.2012

20.9.2012

Leflunomide ratiopharm

ratiopharm GmbH

Graf-Arco-Straße 3, D-89079 Ulm, Deutschland

EU/1/10/654/001-004

24.9.2012

20.9.2012

Mircera

Roche Registration Limited

6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, United Kingdom

EU/1/07/400/008-013

EU/1/07/400/017-024

24.9.2012

20.9.2012

Olanzapine Apotex

Apotex Europe B.V.

Darwingweg 20, 2333 CR Leiden, Nederland

EU/1/10/635/001-018

24.9.2012

20.9.2012

Optaflu

Novartis Vaccines and Diagnostics GmbH

Emil-von-Behring-Strasse 76, D-35041 Marburg, Deutschland

EU/1/07/394/001-009

24.9.2012

20.9.2012

Prialt

Eisai Limited

European Knowledge Centre, Mosquito Way, Hatfield, Herts, AL10 9SN, United Kingdom

EU/1/04/302/001-004

24.9.2012

20.9.2012

Sutent

Pfizer Ltd

Ramsgate Road, Sandwich, Kent CT 13 9NJ, United Kingdom

EU/1/06/347/001-008

24.9.2012

20.9.2012

Tasigna

Novartis Europharm Ltd

Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/07/422/001-012

24.9.2012

20.9.2012

Tesavel

Merck Sharp & Dohme Ltd

Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/07/435/001-018

24.9.2012

20.9.2012

Torisel

Pfizer Limited

Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom

EU/1/07/424/001

24.9.2012

20.9.2012

VELCADE

Janssen-Cilag International NV

Turnhoutseweg 30, B-2340 Beerse, België

EU/1/04/274/001-002

24.10.2012

20.9.2012

Xeloda

Roche Registration Limited

6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, United Kingdom

EU/1/00/163/001-002

24.9.2012

24.9.2012

alli

Glaxo Group Limited

Glaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex UB6 0NN, United Kingdom

EU/1/07/401/007-016

26.9.2012

24.9.2012

Elaprase

Shire Human Genetic Therapies AB

Svärdvägen 11D, 182 33 Danderyd, Sverige

EU/1/06/365/001-003

26.9.2012

24.9.2012

Komboglyze

Bristol Myers Squibb/AstraZeneca EEIG

Bristol Myers Squibb House, Uxbridge Business Park, Sanderson Road, Uxbridge, Middlesex UB8 1DH, United Kingdom

EU/1/11/731/004-005

EU/1/11/731/010-011

EU/1/11/731/013-014

24.9.2012

24.9.2012

Nevanac

Alcon Laboratories (UK) Ltd.

Boundary Way, Hemel Hempstead, Herts HP2 7UD, United Kingdom

EU/1/07/433/001

26.9.2012

24.9.2012

PecFent

Archimedes Development Ltd

Nottingham, NGT7 2TN, United Kingdom

EU/1/10/644/001-006

27.9.2012

24.9.2012

Pramipexole Accord

Accord Healthcare Limited

5th Floor Charles House, 108/110 Finchley road, London NW3 5JJ, United Kingdom

EU/1/11/728/001-010

24.9.2012

24.9.2012

Revasc

Canyon Pharmaceuticals Ltd

7th Floor, 52-54 Gracechurch Street, London EC3V OEH, United Kingdom

EU/1/97/043/001-003

26.9.2012

24.9.2012

Torisel

Pfizer Limited

Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom

EU/1/07/424/001

26.9.2012

24.9.2012

Xenical

Roche Registration Limited

6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, United Kingdom

EU/1/98/071/001-006

26.9.2012

28.9.2012

Irbesartan Zentiva

Sanofi

54, rue La Boétie, 75008 Paris, France

EU/1/06/376/001-039

3.10.2012

28.9.2012

Matever

Pharmathen S.A.

6 Dervenakion, 15351 Pallini Attiki, Ελλάδα

EU/1/11/711/001-030

3.10.2012

28.9.2012

Pegasys

Roche Registration Limited

6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, United Kingdom

EU/1/02/221/001-016

3.10.2012


—   Ħruġ ta' awtorizzazzjoni għat-tqegħid fis-suq (Artikolu 13 tar-Regolament (KE) Nru 726/2004 tal-Parlament Ewropew u tal-Kunsill): Miċħud

Data tad-deċiżjoni

Isem tal-prodott mediċinali

Detentur tal-awtorizzazzjoni għat-tqegħid fis-suq

Numru tal-entrata fir-Reġistru Komunitarju

Data ta' notifika

28.9.2012

Libertek

Nycomed GmbH

Byk-Gulden-Str. 2, D-78467 Konstanz, Deutschland

–

4.10.2012


—   Irtirar ta' awtorizzazzjoni għat-tqegħid fis-suq (Artikolu 13 tar-Regolament (KE) Nru 726/2004 tal-Parlament Ewropew u tal-Kunsill)

Data tad-deċiżjoni

Isem tal-prodott mediċinali

Detentur tal-awtorizzazzjoni għat-tqegħid fis-suq

Numru tal-entrata fir-Reġistru Komunitarju

Data ta' notifika

10.9.2012

Rivastigmine Teva

Teva Pharma B.V.

Computerweg 10, 3542 DR Utrecht, Nederland

EU/1/09/513/001-020

12.9.2012


—   Modifika ta' awtorizzazzjoni għat-tqegħid fis-suq (Artikolu 38 tar-Regolament (KE) Nru 726/2004 tal-Parlament Ewropew u tal-Kunsill): Aċċettat

Data tad-deċiżjoni

Isem tal-prodott mediċinali

Detentur tal-awtorizzazzjoni għat-tqegħid fis-suq

Numru tal-entrata fir-Reġistru Komunitarju

Data ta' notifika

3.9.2012

BTVPUR AlSap 8

MERIAL

29 avenue Tony Garnier, 69007 LYON, France

EU/2/09/094/001-005

5.9.2012

10.9.2012

TruScient

Pfizer Limited

Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom

EU/2/11/136/001

12.9.2012

10.9.2012

Veraflox

Bayer Animal Health GmbH

51368 Leverkusen, Deutschland

EU/2/10/107/001-014

12.9.2012

11.9.2012

Porcilis PCV

Intervet International B.V.

Wim de Körverstraat 35, 5831 AN Boxmeer, Nederland

EU/2/08/091/001-010

13.9.2012

28.9.2012

SevoFlo

Abbott Laboratories Limited

Abbott House, Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire SL6 4XE, UNITED KINGDOM

EU/2/02/035/007

5.10.2012

Kull min jixtieq jikkonsulta r-rapport ta' evalwazzjoni pubblika dwar il-prodotti mediċinali kkonċernati u d-deċiżjonijiet marbuta magħhom għandu jikkuntattja lil:

The European Medicines Agency

7, Westferry Circus,

Canary Wharf

UK - LONDON E14 4H

(1)  ĠU L 136, 30.4.2004, p. 1.

Top